This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
Non-alcoholic fatty liver disease: A patient guideline / Francque, Sven M; Marchesini, Giulio; Kautz, Achim; Walmsley, Martine; Dorner, Rebecca; Lazarus, Jeffrey V; Zelber-Sagi, Shira; Hallsworth, Kate; Busetto, Luca; Frühbeck, Gema; Dicker, Dror; Woodward, Euan; Korenjak, Marko; Willemse, José; Koek, Gerardus H; Vinker, Shlomo; Ungan, Mehmet; Mendive, Juan M; Lionis, Christos. - In: JHEP REPORTS. - ISSN 2589-5559. - ELETTRONICO. - 3:5(2021), pp. 100322-100322. [10.1016/j.jhepr.2021.100322]
Non-alcoholic fatty liver disease: A patient guideline
Marchesini, Giulio;
2021
Abstract
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and comes with a high disease burden. Yet, there is a lot of unawareness. Furthermore, many aspects of the disease are still to be unravelled, which has an important impact on the information that is given (or not) to patients. Its management requires a close interaction between patients and their many healthcare providers. It is important for patients to develop a full understanding of NAFLD in order to enable them to take an active role in their disease management. This guide summarises the current knowledge relevant to NAFLD and its management. It has been developed by patients, patient representatives, clinicians and scientists and is based on current scientific recommendations, intended to support patients in making informed decisions. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
